Allied Market Research

2024

Wet Age-related Macular Degeneration (amd) Drugs Market

Wet Age-Related Macular Degeneration (AMD) Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report by Type (LUCENTIS, AVASTIN, EYLEA, OTHER DRUGS) and by END USER (HOSPITALS, OPHTHALMIC CLINICS, RESEARCH INSTITUTES, CONTRACT RESEARCH ORGANIZATIONS): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Wet Age-Related Macular Degeneration (AMD) Drugs Market Report Highlights

Aspects Details
Wet Age-Related Macular Degeneration (AMD) Drugs Market By Type
By Type
  • LUCENTIS
  • AVASTIN
  • EYLEA
  • OTHER DRUGS
Wet Age-Related Macular Degeneration (AMD) Drugs Market By END USER
By END USER
  • HOSPITALS
  • OPHTHALMIC CLINICS
  • RESEARCH INSTITUTES
  • CONTRACT RESEARCH ORGANIZATIONS
Wet Age-Related Macular Degeneration (AMD) Drugs Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Pfizer Inc., Sanofi, Bayer AG, Novartis AG, Allergan plc, Santen Pharmaceutical Co. Ltd., Roche Holding AG, Genentech Inc., Ophthotech Corporation, Regeneron Pharmaceuticals Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Wet Age-related Macular Degeneration (amd) Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032